Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome

PaperCitations, authors & open-access status

Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 62 citations, 2018 year and hybrid oa status.

62
Citations
2018
Year
hybrid
OA Status

Related on ScholarIQ

Lisa Tran
Author
Cutaneous lymphoproliferative disorders research
Topic
Cutaneous lymphoproliferative disorders research
Topic
CAR-T cell therapy research
Topic
Immunotherapy and Immune Responses
Topic
470M+ articles · free account